Skip to main content

Clinical Trials Using Carboplatin

Review the clinical trials studying carboplatin on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 151-175 of 266

Pembrolizumab with or without Chemotherapy for the Treatment of Black Patients with Advanced or Metastatic Non Small Cell Lung Cancer
Status: Active
Location: 2 locations
Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC after Chemoradiation and Anti-PD-L1 Therapy
Status: Active
Location: 2 locations
Early Clinical Response Correlation to Pathologic Outcome for Treatment in Patients with Invasive Breast Cancer Undergoing Chemotherapy Before Surgery
Status: Active
Location: 2 locations
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
Status: Active
Location: 3 locations
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
Status: Active
Location: 2 locations
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
Status: Active
Location: 3 locations
Frontline Immunotherapy Combined with Radiation and Chemotherapy in High Risk Endometrial Cancer, FIERCE Study
Status: Active
Location: 2 locations
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
Status: Active
Location: 2 locations
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
Status: Active
Location: 2 locations
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
Status: Active
Location: 4 locations
Immunosensitizing Radiation with Neoadjuvant Chemoimmunotherapy for the Treatment of Patients with Stage II-IIIC Borderline Resectable Non-Small Cell Lung Cancer, The NeoRADjuvant Trial
Status: Active
Location: 2 locations
Papaverine in Combination with Chemoradiation for the Treatment of Stage II, III, or IV Non-small Cell Lung Cancer
Status: Active
Location: 2 locations
Implantable Microdevice for Evaluating Drug Responses in Patients with Head and Neck Cancers, the Window of Opportunity Study
Status: Active
Location: 2 locations
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
Status: Active
Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri
A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer
Status: Active
Location: Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Status: Active
Location: 4 locations
Gemcitabine and Carboplatin for the Treatment of Locally Advanced or Metastatic, Progressive Urothelial Carcinoma
Status: Active
Location: Fox Chase Cancer Center, Philadelphia, Pennsylvania
Immunotherapy (Pembrolizumab) with Chemotherapy and Chemoradiation for the Treatment of Stage II-IVb Squamous Cell Cancer of the Nasal Cavity and Paranasal Sinuses, the I-NAPA Study
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer
Status: Active
Location: University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland
Combination Chemotherapy and Radiation Therapy in Treating Patients with Newly Diagnosed Stage I-II Nasal NK Cell Lymphoma
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Pulsed Dose Chemotherapy Plus Pembrolizumab for First Line Treatment of Recurrent or Metastatic HNSCC
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Tiragolumab with Carboplatin, Pemetrexed, and Atezolizumab for the Treatment of Non-squamous Non-small Cell Lung Cancer and Untreated Brain Metastases
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
First Line Chemotherapy (Carboplatin and Paclitaxel) and Immunotherapy (Pembrolizumab) for the Treatment of Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma
Status: Active
Location: Wake Forest University Health Sciences, Winston-Salem, North Carolina
Reduced Dose Chemotherapy in Combination with Immunotherapy for the Treatment of Stage IV Non-small Cell Lung Cancer in Vulnerable or Older Adults with a PD-L1 Tumor Proportion Score < 50%
Status: Active
Location: VCU Massey Comprehensive Cancer Center, Richmond, Virginia